0.5817
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Neuroone Medical Technologies Corp Borsa (NMTC) Ultime notizie
NeuroOne Medical (NMTC) Enhances Leadership with New General Cou - GuruFocus
NeuroOne Cuts Legal Costs with Strategic General Counsel Hire: Former Partner Joins Executive Team - Stock Titan
NeuroOne CEO to Meet Investors at MedInvest Conference: Spotlight on Neural Surgery Innovation - Stock Titan
NeuroOne Medical Technologies (NASDAQ:NMTC) Trading 1.1% Higher – Should You Buy? - Defense World
NeuroOne Completes FDA Submission for OneRF Trigeminal Nerve Ablation System - Medical Product Outsourcing
NeuroOne Medical Technologies Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
NMTC Achieves Growth in Q2 with Advancements in OneRF Technology - GuruFocus
Earnings call transcript: NeuroOne Medical beats EPS expectations in Q1 2025 - Investing.com Canada
NeuroOne Medical Technologies Corp (NMTC) Q2 2025 Earnings Call Highlights: Revenue Surge and ... - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Q2 2025 Earnings Call - GuruFocus
NeuroOne Medical Technologies Corp Reports Q2 FY2025 Earnings: E - GuruFocus
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6% - Stock Titan
NeuroOne Medical (NMTC) Welcomes New Chief Medical Advisor | NMT - GuruFocus
NeuroOne Medical Technologies (NMTC) Appoints New Chief Medical Advisor - GuruFocus
NeuroOne appoints Dr. Patil as Chief Medical Advisor - Investing.com
NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor - Stock Titan
NeuroOne Medical Opens Exclusive Investor Access: CFO Hosts One-on-One Meetings at Plaza Hotel - Stock Titan
NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
NeuroOne Medical Tech (NMTC) Coverage Initiated by Ladenburg Tha - GuruFocus
This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Geode Capital Management LLC Grows Stake in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) - Defense World
NeuroOne Earnings: Medical Tech Leader to Reveal Q2 2025 Growth Strategy and Financial Results - Stock Titan
NeuroOne Medical Technologies Corp [NMTC] Records 50-Day SMA of $0.8911 - knoxdaily.com
NeuroOne Medical Technologies Corp’s results are impressive - uspostnews.com
The Future of NeuroOne Medical Technologies Corp: Analyzing NMTC - investchronicle.com
NeuroOne Medical (NMTC) Files Early FDA Submission for Trigemina - GuruFocus
NeuroOne Medical (NMTC) Files Early FDA Submission for Trigeminal Nerve Ablation | NMTC Stock News - GuruFocus
NeuroOne files early FDA 510(k) for nerve ablation system - Investing.com
NeuroOne's Revolutionary Facial Pain Treatment Advances: FDA Review Next for 95% Effective Device - Stock Titan
EXCLUSIVE: NeuroOne Submits FDA Marketing Application For OneRF Trigeminal Nerve Ablation System For Facial Pain - Benzinga
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Regulatory Success ... - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call - GuruFocus
CTEK Expects Significant Revenue Growth by Fiscal Year 2025 | NMTC Stock News - GuruFocus
NeuroOne Medical (NMTC) Expands Partnership with Zimmer Biomet and Secures Funding | NMTC Stock News - GuruFocus
Neuroone Medical Technologies Corp -Company Now Fully Funded Through At Least Fiscal 2026 - marketscreener.com
NeuroOne secures funding through fiscal 2026, unaffected by tariffs - Investing.com
NeuroOne Secures $11.3M in Fresh Capital, Forecasts Triple-Digit Growth - Stock Titan
NeuroOne Medical (NMTC) Gains Attention with Successful Pediatric Epilepsy Treatment | NMTC Stock News - GuruFocus
Breakthrough: Teen Goes from 10 Seizures Per Night to Zero with New Brain Treatment - Stock Titan
Teen goes from 10 nightly seizures to zero with brain implant - Fox News
Ronald McClurg Spends US$100k On NeuroOne Medical Technologies Stock - Yahoo
NeuroOne Medical Technologies CEO buys $50,000 in common stock By Investing.com - Investing.com India
NeuroOne Medical Technologies CEO buys $50,000 in common stock - Investing.com Australia
NeuroOne Medical’s CFO Ronald McClurg buys $100,000 in stock By Investing.com - Investing.com South Africa
NeuroOne Medical's CFO Ronald McClurg buys $100,000 in stock - Investing.com
NeuroOne Executives Make Significant Stock Purchases - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet - Benzinga
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):